Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 HKD | -1.20% | -13.01% | -42.09% |
Business Summary
Number of employees: 6,937
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Life-science Services and Products
55.9
%
| 2,378 | 59.9 % | 2,739 | 55.9 % | +15.20% |
Biologics Development Services
19.2
%
| 624 | 15.7 % | 941 | 19.2 % | +50.83% |
Cell Therapy
18.6
%
| 671 | 16.9 % | 914 | 18.6 % | +36.09% |
Industrial Synthetic Biology Products
6.1
%
| 297 | 7.5 % | 299 | 6.1 % | +0.82% |
Operation Unit
0.1
%
| 3 | 0.1 % | 7 | 0.1 % | +144.12% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
53.1
%
| 2,077 | 52.3 % | 2,600 | 53.1 % | +25.21% |
China
26.7
%
| 1,122 | 28.2 % | 1,306 | 26.7 % | +16.37% |
Asia Pacific (excluding China)
9.4
%
| 329 | 8.3 % | 462 | 9.4 % | +40.25% |
Europe
8.5
%
| 337 | 8.5 % | 417 | 8.5 % | +23.67% |
Others
2.3
%
| 107 | 2.7 % | 114 | 2.3 % | +6.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Weihui Shao
CEO | Chief Executive Officer | - | 22-12-31 |
Ye Wang
FOU | Founder | 55 | 01-12-31 |
Shiniu Wei
DFI | Director of Finance/CFO | - | - |
Jian Ge Meng
CHM | Chairman | 56 | 10-03-31 |
Li Zhu
BRD | Director/Board Member | 74 | 09-12-31 |
Berkan Unal
PRN | Corporate Officer/Principal | - | - |
Jing Jing Hua
AUD | Comptroller/Controller/Auditor | - | - |
Wai Ling Wong
SEC | Corporate Secretary | 45 | 15-08-23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Xin Guo
BRD | Director/Board Member | 61 | 15-08-23 |
Li Zhu
BRD | Director/Board Member | 74 | 09-12-31 |
Xue Hai Wang
BRD | Director/Board Member | 50 | 20-11-21 |
Jia Fen Wang
BRD | Director/Board Member | 73 | 18-11-25 |
Zu Mian Dai
BRD | Director/Board Member | 47 | 15-08-23 |
Fang Liang Zhang
CEO | Chief Executive Officer | 59 | 01-12-31 |
Lu Quan Wang
FOU | Founder | 54 | 01-12-31 |
Ye Wang
FOU | Founder | 55 | 01-12-31 |
Jian Ge Meng
CHM | Chairman | 56 | 10-03-31 |
Jiu An Pan
BRD | Director/Board Member | 56 | 18-11-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,124,027,670 | 1,147,890,976 ( 54.04 %) | 0 | 54.04 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
LEGEND BIOTECH CORPORATION 60.32% | 174,497,556 | 60.32% | 4,893,783,958 $ |
Company contact information
Genscript Biotech Corp.
No. 28, Yongxi Road Jiangning Science Park
210000, Nanjing
+86 25 5889 7288
http://www.genscript.comGroup companies
Name | Category and Sector |
---|---|
Pharmaceuticals: Major
| |
Probio Technology Ltd. (George Town)
Probio Technology Ltd. (George Town) BiotechnologyHealth Technology Probio Technology Ltd. (Cayman Islands) is a company based in George Town, the Cayman Islands. |
Biotechnology
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.09% | 3.16B | |
-1.64% | 41.71B | |
+47.70% | 41.56B | |
+3.49% | 39.74B | |
-15.14% | 25.61B | |
+3.00% | 24.26B | |
-23.37% | 18.55B | |
-2.46% | 11.93B | |
+25.14% | 11.93B | |
+7.49% | 10.91B |
- Stock Market
- Equities
- 1548 Stock
- Company Genscript Biotech Corporation